SUBSTITUTED (4-AMINOCYCLOHEXEN-1-YL)PHENYL AND (4-AMINOCYCLOHEXEN-1-YL)PYRIDINYL COMPOUNDS AS 5-HT1F AGONISTS
    6.
    发明授权
    SUBSTITUTED (4-AMINOCYCLOHEXEN-1-YL)PHENYL AND (4-AMINOCYCLOHEXEN-1-YL)PYRIDINYL COMPOUNDS AS 5-HT1F AGONISTS 有权
    取代基(4-氨基环戊烯-1-基)苯基和(4-氨基环己烷-1-基)吡啶基缬氨二醛5-HT1F AGONISTEN

    公开(公告)号:EP1697305B1

    公开(公告)日:2007-08-15

    申请号:EP04816953.6

    申请日:2004-12-06

    摘要: The present invention relates to compounds of formula (I) or a pharmaceutically acceptable acid addition salt thereof, where; X is -C(R4)= or -N=; Ar is phenyl, substituted phenyl, heterocycle, or substituted heterocycle; R1 and R2 are independantly hydrogen or C1-C3 alkyl; R3 is hydrogen, fluoro, or methyl; when X is -C(R4)=, R4 is hydrogen, fluoro, or methyl, provided that no more than one of R3 and R4 may be other than hydrogen; and R5 is hydrogen, methyl, or ethyl. The compounds of the present invention are useful for activating 5-HT1F receptors, inhibiting dural protein extravasation, and for the treatment or prevention of migraine in a mammal.

    摘要翻译: 本发明涉及式I化合物或其药学上可接受的酸加成盐,其中: X是-C(R 4) - 或-N-; Ar是苯基,取代的苯基,杂环或取代的杂环; R 1和R 2独立地是氢或C 1 -C 3烷基; R 3是氢,氟或甲基; 当X是-C(R 4) - )时,R 4是氢,氟或甲基,条件是R 3不超过一个 >和R 4可以不同于氢; R 5是氢,甲基或乙基。 本发明的化合物可用于活化5-HT 1F受体,抑制硬脑膜蛋白质外渗,以及治疗或预防哺乳动物偏头痛。